BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7126178)

  • 21. Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin.
    Yamada S; Yoshida K; Sugiura M; Sugahara K; Khoo KH; Morris HR; Dell A
    J Biol Chem; 1993 Mar; 268(7):4780-7. PubMed ID: 8444855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.
    Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA
    Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic studies on chemically synthesized pentasaccharide and tetrasaccharide fragments.
    Choay J
    Semin Thromb Hemost; 1985 Apr; 11(2):81-5. PubMed ID: 4035368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
    Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
    Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
    Austin RC; Rachubinski RA; Ofosu FA; Blajchman MA
    Blood; 1991 May; 77(10):2185-9. PubMed ID: 2029579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP; Merton RE; Barrowcliffe TW; Thunberg L; Lindahl U
    Thromb Haemost; 1982 Jun; 47(3):244-8. PubMed ID: 7112499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple functional domains of the heparin molecule.
    Oosta GM; Gardner WT; Beeler DL; Rosenberg RD
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):829-33. PubMed ID: 6940150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1H NMR spectroscopic studies on the interactions between human plasma antithrombin III and defined low molecular weight heparin fragments.
    Horne A; Gettins P
    Biochemistry; 1992 Mar; 31(8):2286-94. PubMed ID: 1311598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From heparin to heparin fractions and derivatives.
    Coyne E
    Semin Thromb Hemost; 1985 Jan; 11(1):10-2. PubMed ID: 3883496
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative studies on the structures of highly active and relatively inactive forms of whale heparin.
    Ototani N; Kikuchi M; Yosizawa Z
    J Biochem; 1981 Jul; 90(1):241-6. PubMed ID: 7287679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the molecular-weight-dependence of the anticoagulant activity of heparin.
    Thunberg L; Lindahl U; Tengblad A; Laurent TC; Jackson CM
    Biochem J; 1979 Jul; 181(1):241-43. PubMed ID: 486155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extension and structural variability of the antithrombin-binding sequence in heparin.
    Lindahl U; Thunberg L; Bäckström G; Riesenfeld J; Nordling K; Björk I
    J Biol Chem; 1984 Oct; 259(20):12368-76. PubMed ID: 6490618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.